re
Regeneron Pharmaceuticals
REGN
NASDAQ $747.29
How effective is Regeneron Pharmaceuticals's capital allocation strategy?
Regeneron Pharmaceuticals shows solid capital allocation. Returns on capital exceed the cost of capital, and management balances reinvestment with shareholder returns reasonably well. There is room for improvement, but overall capital deployment creates value.
Read the full report on Regeneron Pharmaceuticals and explore the other sections
Overview of Regeneron Pharmaceuticals
Does Regeneron Pharmaceuticals have a strong competitive moat?
Does Regeneron Pharmaceuticals have pricing power in its industry?
How predictable is Regeneron Pharmaceuticals's business?
Is Regeneron Pharmaceuticals financially strong?
How effective is Regeneron Pharmaceuticals's capital allocation strategy?
Does Regeneron Pharmaceuticals have high-quality management?
What is the fair value of Regeneron Pharmaceuticals stock?